A three-judge panel of the Federal Circuit appeared split at oral argument on Dana-Farber Cancer Institute’s claims that a Nobel Prize winner’s fellow researchers should be named on his cancer immunotherapy patents.
Japan-based
U.S. Court of Appeals for the Federal Circuit Judges Alan D. Lourie and Kara F. Stoll had hard questions for the drug companies.
“The district court found that all three doctors ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
